BioWorld 16 abr 2026 Corbus Pharmaceuticals synthesizes new cannabinoid CB1 receptor antagonists or inverse agonists Corbus Pharmaceuticals synthesizes new cannabinoid CB1 receptor antagonists or inverse agonists Original